Augmedix, Inc. financial data

Location
San Francisco, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q2 2024 - 12 Aug 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 186% % 7.1%
Debt-to-equity 322% % -80%
Return On Equity -182% % 81%
Return On Assets -43% % 25%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 49,243,752 shares 21%
Common Stock, Shares, Outstanding 49,080,486 shares 20%
Common Stock, Value, Issued $5,000 USD 25%
Weighted Average Number of Shares Outstanding, Basic 53,387,349 shares 22%
Weighted Average Number of Shares Outstanding, Diluted 53,387,349 shares 22%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $13,664,000 USD 27%
Research and Development Expense $14,127,000 USD 34%
Selling and Marketing Expense $12,787,000 USD 30%
General and Administrative Expense $21,835,000 USD 24%
Operating Income (Loss) $23,878,000 USD -14%
Nonoperating Income (Expense) $97,000 USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $23,781,000 USD -12%
Income Tax Expense (Benefit) $67,000 USD -61%
Net Income (Loss) Attributable to Parent $23,848,000 USD -12%
Earnings Per Share, Basic 0 USD/shares 16%
Earnings Per Share, Diluted 0 USD/shares 16%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $28,220,000 USD 15%
Accounts Receivable, after Allowance for Credit Loss, Current $9,252,000 USD -1.9%
Assets, Current $39,925,000 USD 11%
Property, Plant and Equipment, Net $3,333,000 USD 28%
Operating Lease, Right-of-Use Asset $4,431,000 USD 22%
Assets $53,672,000 USD 22%
Accounts Payable, Current $881,000 USD -45%
Employee-related Liabilities, Current $2,440,000 USD 11%
Contract with Customer, Liability, Current $8,902,000 USD
Liabilities, Current $23,995,000 USD 13%
Operating Lease, Liability, Noncurrent $3,303,000 USD 36%
Other Liabilities, Noncurrent $360,000 USD
Liabilities $43,198,000 USD 8.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax $1,100,000 USD -43%
Retained Earnings (Accumulated Deficit) $159,911,000 USD -18%
Stockholders' Equity Attributable to Parent $10,474,000 USD 163%
Liabilities and Equity $53,672,000 USD 22%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $8,236,000 USD -32%
Net Cash Provided by (Used in) Financing Activities $59,000 USD -99%
Net Cash Provided by (Used in) Investing Activities $542,000 USD -213%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 49,080,486 shares 20%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $8,707,000 USD -545%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $33,427,000 USD 32%
Interest Paid, Excluding Capitalized Interest, Operating Activities $430,000 USD 53%
Operating Lease, Liability $4,734,000 USD 21%
Depreciation $416,000 USD 59%
Payments to Acquire Property, Plant, and Equipment $568,000 USD 228%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $8,644,000 USD -62%
Lessee, Operating Lease, Liability, to be Paid $5,507,000 USD 23%
Property, Plant and Equipment, Gross $7,054,000 USD -25%
Operating Lease, Liability, Current $1,432,000 USD -2.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,695,000 USD 15%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,636,000 USD 125%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 29%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $773,000 USD 36%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,021,000 USD 33%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares
Lessee, Operating Lease, Liability, to be Paid, Year Four $459,000 USD -27%
Operating Lease, Payments $363,000 USD 61%
Additional Paid in Capital $171,480,000 USD 22%
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares